JESSICA LEIST: Open Payments
NPI 1174778286 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 6 payments from 5 companies in 2025. Trend: 2023 $38 · 2024 $0 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $114 |
| Madrigal Pharmaceuticals | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Kerecis Limited | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
Products named: XIFAXAN, REZDIFFRA, GATTEX, Kerecis SurgiClose, PREVELEAK.
Industry payments across TX — which companies pay providers there.
